Sunrun Valuation
Is RUN * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RUN * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate RUN *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate RUN *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RUN *?
Other financial metrics that can be useful for relative valuation.
What is RUN *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$3.07b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.4x |
Enterprise Value/EBITDA | -72.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does RUN *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.5x | ||
ALFA A Alfa. de | 0.2x | 0.8% | Mex$50.5b |
LAMOSA * Grupo Lamosa. de | 1.4x | n/a | Mex$43.1b |
IDEAL B-1 Impulsora del Desarrollo y el Empleo en América Latina. de | 4.1x | n/a | Mex$111.5b |
KUO B Grupo KUO. de | 0.5x | n/a | Mex$17.7b |
RUN * Sunrun | 1.4x | 12.2% | Mex$3.1b |
Price-To-Sales vs Peers: RUN * is good value based on its Price-To-Sales Ratio (1.4x) compared to the peer average (1.5x).
Price to Earnings Ratio vs Industry
How does RUN *'s PE Ratio compare vs other companies in the Global Electrical Industry?
Price-To-Sales vs Industry: RUN * is good value based on its Price-To-Sales Ratio (1.4x) compared to the Global Electrical industry average (1.7x).
Price to Sales Ratio vs Fair Ratio
What is RUN *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.4x |
Fair PS Ratio | 0.4x |
Price-To-Sales vs Fair Ratio: RUN * is expensive based on its Price-To-Sales Ratio (1.4x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$255.00 | Mex$364.83 +43.1% | 38.9% | Mex$775.46 | Mex$221.56 | n/a | 25 |
Jun ’25 | Mex$243.99 | Mex$328.30 +34.6% | 38.4% | Mex$704.94 | Mex$201.41 | n/a | 25 |
May ’25 | Mex$176.50 | Mex$345.59 +95.8% | 40.1% | Mex$731.77 | Mex$204.21 | n/a | 27 |
Apr ’25 | Mex$212.00 | Mex$354.35 +67.1% | 36.5% | Mex$712.26 | Mex$198.77 | n/a | 28 |
Mar ’25 | Mex$212.00 | Mex$368.51 +73.8% | 36.4% | Mex$733.86 | Mex$204.80 | n/a | 27 |
Feb ’25 | Mex$253.00 | Mex$391.02 +54.6% | 38.5% | Mex$734.72 | Mex$170.87 | n/a | 26 |
Jan ’25 | Mex$336.00 | Mex$371.23 +10.5% | 41.3% | Mex$737.56 | Mex$171.53 | n/a | 28 |
Dec ’24 | Mex$238.00 | Mex$345.32 +45.1% | 42.6% | Mex$735.64 | Mex$171.08 | n/a | 27 |
Nov ’24 | Mex$173.00 | Mex$475.64 +174.9% | 45.5% | Mex$1,062.61 | Mex$219.85 | n/a | 26 |
Oct ’24 | Mex$217.00 | Mex$581.45 +167.9% | 32.7% | Mex$1,034.11 | Mex$361.94 | n/a | 25 |
Sep ’24 | Mex$270.00 | Mex$577.97 +114.1% | 32.4% | Mex$1,023.08 | Mex$358.08 | n/a | 25 |
Aug ’24 | Mex$318.00 | Mex$577.16 +81.5% | 31.9% | Mex$1,009.72 | Mex$336.57 | n/a | 25 |
Jul ’24 | Mex$298.00 | Mex$613.33 +105.8% | 29.2% | Mex$1,030.58 | Mex$429.41 | n/a | 25 |
Jun ’24 | Mex$324.00 | Mex$630.65 +94.6% | 29.2% | Mex$1,070.48 | Mex$446.03 | Mex$243.99 | 25 |
May ’24 | Mex$370.00 | Mex$678.99 +83.5% | 30.5% | Mex$1,168.89 | Mex$413.61 | Mex$176.50 | 26 |
Apr ’24 | Mex$352.59 | Mex$737.90 +109.3% | 30.0% | Mex$1,171.46 | Mex$486.60 | Mex$212.00 | 23 |
Mar ’24 | Mex$452.19 | Mex$761.66 +68.4% | 27.4% | Mex$1,176.69 | Mex$488.78 | Mex$212.00 | 23 |
Feb ’24 | Mex$520.00 | Mex$833.38 +60.3% | 27.3% | Mex$1,318.07 | Mex$564.89 | Mex$253.00 | 22 |
Jan ’24 | Mex$462.00 | Mex$912.51 +97.5% | 28.3% | Mex$1,422.48 | Mex$553.18 | Mex$336.00 | 24 |
Dec ’23 | Mex$594.85 | Mex$883.96 +48.6% | 28.4% | Mex$1,379.21 | Mex$536.36 | Mex$238.00 | 24 |
Nov ’23 | Mex$448.50 | Mex$953.46 +112.6% | 27.9% | Mex$1,574.46 | Mex$518.18 | Mex$173.00 | 22 |
Oct ’23 | Mex$580.00 | Mex$1,009.21 +74.0% | 25.3% | Mex$1,589.72 | Mex$603.69 | Mex$217.00 | 23 |
Sep ’23 | Mex$633.00 | Mex$973.57 +53.8% | 27.5% | Mex$1,589.39 | Mex$603.56 | Mex$270.00 | 22 |
Aug ’23 | Mex$620.00 | Mex$914.86 +47.6% | 30.3% | Mex$1,432.82 | Mex$552.66 | Mex$318.00 | 21 |
Jul ’23 | Mex$490.00 | Mex$943.71 +92.6% | 30.0% | Mex$1,407.52 | Mex$542.90 | Mex$298.00 | 21 |
Jun ’23 | Mex$496.00 | Mex$1,007.82 +103.2% | 31.0% | Mex$1,792.04 | Mex$543.65 | Mex$324.00 | 19 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.